Paper Details

  1. Home
  2. Paper Details

Therapeutic potential of choline magnesium trisalicylate as an alternative to aspirin for patients with bleeding tendencies.

Author: DaneshB J, LoweG D, RussellR I, SaniabadiA R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

The effects of acetyl salicylic acid (ASA, aspirin) and choline magnesium trisalicylate (CMT), a non-acetylated salicylate, on platelet aggregation were compared in human whole blood ex vivo. Although both drugs had comparable salicylic acid absorption, ASA significantly inhibited platelet aggregation induced by collagen, arachidonic acid, and spontaneously, while CMT did not. CMT may be a potential alternative to aspirin when platelet aggregation inhibition could lead to bleeding complications.
Paper Details　
Original Abstract of the Article :
We have compared the effects of acetyl salicylic acid (ASA, aspirin) and choline magnesium trisalicylate (CMT), a non-acetylated salicylate product, on platelet aggregation in human whole blood ex-vivo. Using a whole blood platelet counter, platelet aggregation was quantified by measuring the fall i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/003693308703200603

データ提供：米国国立医学図書館（NLM）

Choline Magnesium Trisalicylate: A Potential Alternative to Aspirin

Aspirin is a widely used medication with a variety of therapeutic benefits, but it can also pose a risk of bleeding complications. This study investigates the potential of choline magnesium trisalicylate (CMT) as a safer alternative to aspirin for patients with bleeding tendencies. It's like searching for a more sustainable source of water in a drought-stricken desert, seeking a solution that balances effectiveness with safety.

Exploring the Potential of CMT

The study compares the effects of aspirin and CMT on platelet aggregation, a key factor in blood clotting. The results show that while aspirin significantly inhibits platelet aggregation, CMT does not have this effect. This is like finding a new type of cactus that can thrive in dry conditions without needing the same amount of water as other plants. The study suggests that CMT may be a valuable alternative to aspirin for patients at risk for bleeding complications.

A Safer Approach to Pain Management

The research highlights the importance of considering the potential risks and benefits of medications, especially for patients with specific health concerns. It's like carefully selecting the right tools for a desert expedition, choosing those that minimize risks and maximize safety. The study’s findings offer hope for the development of safer and more effective treatments for patients who need pain relief without the added risk of bleeding complications.

Dr. Camel's Conclusion

This research highlights the importance of exploring alternative medications with improved safety profiles, especially for patients with specific health concerns. It’s like finding a hidden oasis in the desert of pain management, offering a safe and effective haven for those seeking relief from pain. The study provides a valuable stepping stone in the ongoing quest for better and safer pain management solutions.

Date :
  1. Date Completed 1988-06-23
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

3329766

DOI: Digital Object Identifier

10.1177/003693308703200603

Related Literature

Article Analysis
・Effects of choline magnesium trisalicylate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.